Note: Ingredients listed on restricted chemical lists
EC/CAS
500-039-8/25322-69-4
Name of the chemical
polypropyleneglycol
Concentration
≥25-≤50
General Information
Version
5.07
Revision date
2026-05-11
Product name
TriaCode Defoam 50
Emergency telephone
+44 (0) 1978 823456
Icons in SDS
Company Information
company name
Flint Ink (UK) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
MSDS.UnitedKingdom.Ruabon.PI@flintgrp.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Acute Tox. 4, H302
Signal word
Warning
Hazard statements
Harmful if swallowed.
Prevention
P270 - Do not eat, drink or smoke when using this product. P264 - Wash hands thoroughly after handling.
Response
Not applicable.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Acute Tox. 4, H302 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
